Headline Roundup • May 7th, 2025
FDA Appoints COVID Response Critic Dr. Vinay Prasad to Oversee Vaccine Program
Public Health,Health,Vaccines,Life During Covid-19,Coronavirus,Trump Administration,Robert F Kennedy Jr,FDA
Summary from the AllSides News Team
The US Food and Drug Administration (FDA) has selected Dr. Vinay Prasad, who was critical of some COVID-19 public health measures, to lead its program on vaccines and biological drugs.
The Details: Prasad is a professor at the University of California San Francisco who has also made a name for himself as a writer on Substack and commentator on X. Prasad criticized government responses to COVID and questioned whether young males should receive the shot due to showing a higher rate of myocarditis, but called the COVID shot itself “a miraculous, life-saving advance.”
For Context: The FDA falls under the jurisdiction of Health Secretary Robert F. Kennedy Jr., who has been an outspoken critic of several vaccines and other drugs in the past. Prasad’s appointment was announced to staff by FDA head Dr. Marty Makary, and he replaces Dr. Peter Marks, who helped lead the program for 13 years. Prasad has previously criticized Marks in his writings, calling him “anti-data” and “a bobblehead doll that just stamps approval.”
Key Quotes: Marks said, “It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.” Makary reportedly wrote, “(Prasad) brings a great set of skills, energy, and competence to the FDA and I know that he is eager to begin immersing himself in the important work of CBER and the agency as a whole.”
How The Media Covered It: Some outlets, like Newsweek (Center bias) and Axios (Lean Left), framed the pick as the choice of Kennedy. CNN (Lean Left) and Washington Examiner (Lean Right) noted that biotech stocks were down significantly after the announcement.
Written by the AllSides staff (of humans). Learn more. Support our mission. Suggest an improvement to this summary.
Featured Coverage of this Story

Marvin Joseph/The Washington Post/Getty Images/File
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.
Prasad, a professor at the University of California San Francisco, became a harsh critic of the government’s response and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments.
Dr. Vinay Prasad, a known critic of both the pharmaceutical industry and the Food and Drug Administration, has been appointed to lead the FDA's program overseeing vaccines and biotechnology drugs.
FDA Commissioner Dr. Marty Makary announced the decision in a message to staff on Tuesday, lauding Prasad's "long and distinguished history in medicine." The FDA falls under the guidance of Health Secretary Robert F. Kennedy Jr.
Agency commissioner Dr. Marty Makary announced Tuesday that Dr. Vinay Prasad, a prominent COVID–19 vaccine critic, has been appointed to lead the Food and Drug Administration Center, which oversees the approval of vaccines and other biologics products.
Prasad, currently a physician-scientist and professor at the University of California, San Francisco, gained a following during the pandemic for criticizing mask mandates, lockdowns, and COVID-19 vaccine boosters.
AllSides Picks
Blog
IVF Expansions, Gun Deregulations and Abortion Complications: Latest News You Likely Missed
Malayna J. Bizier
May 22nd, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator